Réduction des méfaits

A scoping review of opioid harm reduction interventions for equity-deserving populations

Milaney K, Haines-Saah R, Farkas B, Egunsola O, Mastikhina L, Brown S, Lorenzetti D, Hansen B, McBrien K, Rittenbach K, Hill L, O’Gorman C, Doig C, Cabaj J, Stokvis C, Clement F. , Lancet Reg Health Am. 2022

“I have such a hard time hitting myself, I thought it’d be easier”: perspectives of hospitalized patients on injecting drugs into vascular access devices

Brooks HL, Salvalaggio G, Pauly B, Dong K, Bubela T, Taylor M, Hyshka E., Harm Reduct J. 2022

Response to “Operational and contextual barriers to accessing supervised consumption services in two Canadian cities”

Brooks HL, Speed K, Lopez E, O’Gorman C, Haines-Saah R, Hyshka E., Int J Drug Policy. 2022

Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study

Gehring ND, Speed KA, Wild TC, Pauly B, Salvalaggio G, Hyshka E., Int J Drug Policy. 2022

“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada

Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer MÈ, Rai N, Bernstein S, Fairbairn N., Canada. Int J Drug Policy. 2022

Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada

Ivsins A, MacKinnon L, Bowles JM, Slaunwhite A, Bardwell G., J Urban Health. 2022

Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital

Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, Harrison S, Wood E, Lysyshyn M, Holliday E., Alcohol Depend. 2022

Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada

Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G., Subst Abuse Treat Prev Policy. 2022

Changements dans l’utilisation des sites de consommation supervisée et interventions d’urgence à Montréal, Canada, au cours des douze premiers mois de la pandémie de COVID-19 : une étude de séries temporelles interrompues

Zolopa C., Frères T.D., Leclerc P., Mary J.F., Morissette C., Bruneau J., Hyshka E., Martin N.K., Larney S., International Journal of Drug Policy, 2022

The North American opioid crisis: how effective are supervised consumption sites?

Kennedy MC, Karamouzian M, Marshall BDL., Lancet. 2022

Utiliser des contrôles synthétiques pour estimer les effets à l’échelle de la population des sites de prévention des surdoses récemment mis en place en Ontario, ainsi que des services de consommation et de traitement

Dimitra Panagiotoglou, Jihoon Lim, International Journal of Drug Policy, 2022

Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada

Cassie R, Hayashi K, DeBeck K, Milloy MJ, Cui Z, Strike C, West J, Kennedy MC., Harm Reduct J. 2022

Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada

Feder KA, Choi J, Schluth CG, Hayashi K, DeBeck K, Milloy MJ, Kirk GD, Mehta SH, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Genberg BL., Drug Alcohol Depend. 2022

Beyond co-production: The construction of drug checking knowledge in a Canadian supervised injection facility

Betsos A, Valleriani J, Boyd J, McNeil R., Soc Sci Med. 2022

Motifs de consommation d’alcool, habitudes de consommation à risque et pratiques de réduction des risques chez les personnes vivant l’itinérance et la dépendance à l’alcool à Montréal

Motta-Ochoa R., Incio-Serra N., Brulotte A., Flores-Aranda J., Harm Reduction Journal, 2023

Motifs de consommation d’alcool, habitudes de consommation à risque et pratiques de réduction des risques chez les personnes vivant l’itinérance et la dépendance à l’alcool à Montréal

Motta-Ochoa R., Incio-Serra N., Brulotte A., Flores-Aranda J., Harm Reduction Journal, 2023

Increasing trends and incidence of nonfatal overdose among women sex workers who use drugs in British Columbia: The role of criminalization-related barriers to harm reduction

Argento E, Shannon K, Fairbairn N, Moreheart S, Braschel M, Goldenberg S., Drug Alcohol Depend. 2023

A Hospital-based Managed Alcohol Program in a Canadian Setting

Nolan S, Fairgrieve C, Dong H, Garrod E, van Heukelom H, Parappilly BP, McLean M, Tsui JI, Samet JH., J Addict Med. 2023

The impact of the COVID-19 pandemic on access to supervised consumption programs

Gubskaya E, Kennedy MC, Hayashi K, Cui Z, Milloy MJ, Kerr T., Subst Abuse Treat Prev Policy. 2023

Opportunités et défis pour capturer les blessures graves liées au vapotage chez les enfants et les jeunes canadiens

Chadi N., Richmond S.A., Tulloch T., Grant C.N., Venugopal J., Moore-Hepburn C., Preventive Medicine Reports, 2023

« Un endroit où se sentir en sécurité, se sentir chez soi et s’améliorer » : incluant les connaissances expérientielles des utilisateurs potentiels dans la conception du premier service humide à Montréal, Canada

Motta-Ochoa R., Incio-Serra N., Poliquin H., MacDonald S.A., Huỳnh C., Côté P.-B., Fallu J.-S., Flores-Aranda J., Harm Reduction Journal, 2022

Recommandations pour réduire le risque de psychose défavorable liée à la consommation de cannabis : une revue des preuves publiques axée sur la santé mentale

Fischer B, Hall W, Fidalgo TM, Hoch E, Le Foll B, Medina-Mora ME, Reimer J, Tibbo PG, Jutras-Aswad D., Journal of Dual Diagnosis, 2023

Women who use drugs: engagement in practices of harm reduction care

Austin T, Lavalley J, Parusel S, Collins AB, Olding M, Boyd J., Harm Reduct J. 2023

Recommandations pour réduire le risque de résultats défavorables liés à la consommation de cannabis : une revue des preuves publiques axée sur la santé mentale

Fischer B., Hall W., Fidalgo T.M., Hoch E., Le Foll B., Medina-Mora M.E., Reimer J., Tibbo P.G., Jutras-Aswad D., Journal of Dual Diagnosis, 2023

Assessing options for poppers policy in Canada: A call to action for evidence-based policy reform

Schwartz C, Card K, Elliott R, Hollett K, Jollimore J, Pasic A, Smiley S, Tooley L, Pruden H, Knight R., Int J Drug Policy. 2023

Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies

Giang K, Charlesworth R, Thulien M, Mulholland A, Barker B, Brar R, Pauly B, Fast D., Int J Drug Policy. 2023

Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes

Bardwell G, Ivsins A, Mansoor M, Nolan S, Kerr T., CMAJ. 2023

Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces

Morris H, Bwala H, Wesley J, Hyshka E., Can J Public Health. 2023

Using spatial video geonarratives to improve nursing care for people who use drugs and experience homelessness: A methodology for nurses

Jackson, J., Ewanyshyn, A., Perry, S., Ens, T., Ginn, C., Keanna, C., Armstrong, G., Ajayakumar, J., Curtis, J., & Curtis, A., Journal of Advanced Nursing, 2023

Development of a neural network model to predict the presence of fentanyl in community drug samples

Ti L, Grant CJ, Tobias S, Hore DK, Laing R, Marshall BDL., PLoS One. 2023

Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic

Galarneau LR, Speed K, Taylor M, Hyshka E., Can J Public Health. 2023

Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study

van Draanen J, Hamilton J, Morgan J, Maxwell S, Taylor T, Richardson L, Nolan S., Harm Reduct J. 2023

Differentiating the role of alcohol in young men’s use of substances with sex: A qualitative study

Goodyear T, Oliffe JL, Parent N, Mniszak C, Jenkins E, Knight R., Harm Reduct J. 2023

Unleashing compassionate care: canine-assisted intervention as a promising harm reduction approach to prisonization in Canada and its relevance to forensic psychiatry

Gibson M, Dell CA, Chalmers D, Rath G, Mela M. , Front Psychiatry., 2023

Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study

Mok J, Milloy MJ, Grant C, Lake S, DeBeck K, Hayashi K, Kerr T, Socías ME., Cannabis Cannabinoid Res. 2023

Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis

Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D. Int J Drug Policy. 2023

Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study

Chayama KL, Ng C, Fleming T, Small W, Sue KL, McNeil R., Harm Reduct J. 2023

“They talk to me like a person”: Experiences of People in an Injectable Opioid Agonist Treatment Program: A Qualitative Interpretive Description

Jackson J, Colborne M, Gadimova F, Kennedy M.C., Journal of Addictions Nursing, 2023

Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis

Document d’orientation sur la distribution et l’utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada

Ferguson M, Rittenbach K, Leece P, Adams A, Ali F, Elton-Marshall T, Burmeister C, Brothers TD, Medley A, Choisil P, Strike C, Ng J, Lorenzetti DL, Gallant K, Buxton JA; le groupe d’élaboration des documents d’orientation relative à la naloxone, CMAJ, 2023

Modéliser comme vision : explorer l’impact de la réforme de la justice pénale sur la santé des populations atteintes de troubles liés à l’usage de substances

Martin N.K., Beletsky L., Linas B.P., Bayoumi A., Pollack H., Larney S., Journal of Urban Health, 2023

Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies

Bhuiyan I, Tobias S, Ti L., Am J Drug Alcohol Abuse. 2023

Flawed reports can harm: the case of supervised consumption services in Alberta

Salvalaggio G, Brooks H, Caine V, Gagnon M, Godley J, Houston S, Kennedy MC, Kosteniuk B, Livingston J, Saah R, Speed K, Urbanoski K, Werb D, Hyshka E., Can J Public Health. 2023

Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis

Morris H, Wild TC, Giovannoni M, Haines-Saah R, Koziel J, Schulz P, Bwala H, Kunyk D, Bubela T, Hyshka E., PLoS One. 2023

Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada

Kennedy MC, Dong H, Tobias S, Buxton JA, Lysyshyn M, Tupper KW, Ti L., Am J Prev Med. 2024

Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study

Tobias S, Ferguson M, Palis H, Burmeister C, McDougall J, Liu L, Graham B, Ti L, Buxton JA., Int J Drug Policy. 2024

Using alone at home: What’s missing in housing-based responses to the overdose crisis?

Fleming T, Boyd J, Chayama KL, Knight KR, McNeil R., Reduct J. 2024

Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvement

Fehr F, Lo LA, Nelson C, Nanson K, Diehl L, Nielson K, Reddon H, Walsh Z., Int J Ment Health Nurs. 2024

Author Reply to Letter to the Editor in Response to “Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada”

Kennedy MC, Tobias S, Dong H, Buxton JA, Lysyshyn M, Tupper KW, Ti L., Am J Prev Med. 2024

Effect of modified income assistance payment schedules on substance use service access: Evidence from an experimental study

Robinson K, Laing A, Choi J, Richardson L., Int J Drug Policy. 2024

Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital

Brooks HL, Speed KA, Dong K, Salvalaggio G, Pauly BB, Taylor M, Hyshka E. , PLoS One., 2024

The war on drugs is a war on us: young people who use drugs and the fight for harm reduction in the Global South

Stowe MJ, Gatonye R, Maharjan I, Kehinde S, Arya S, Valderrábano JH, Mcbride A, Scheibein F, Igonya EK, Fast D., Harm Reduct J. 2024

“The machine doesn’t judge”: Counternarratives on surveillance among people accessing a safer opioid supply via biometric machines

Bardwell G, Ivsins A, Wallace JR, Mansoor M, Kerr T., Soc Sci Med. 2024

Accès et utilisation de la naloxone à domicile chez les personnes âgées vivant avec la douleur : une revue d’analyse

Chan RRD, Yakiwchuk EM, Halpape K., Can J Hosp Pharm., 2024

Characterizing Use of Supervised Consumption Services among Street-involved Youth and Young Adults in the Context of an Overdose Crisis

Lee-Pii K, DeBeck K, Choi J, Sedgemore KO, Kerr T, Kennedy MC., J Urban Health. 2024

Consommation de substances sexualisées chez les GB-MSM : leurs perspectives sur leurs besoins d’intervention et leurs compétences de conseillers

Blanchette M., Flores-Aranda J., Bertrand K., Lemaître A., Jauffret-Roustide M., Goyette M., Journal of Substance Use and Addiction Treatment, 2024

Différences de sexe et de genre dans le risque, la prévention et la cascade de soins du virus de l’hépatite C chez les personnes qui injectent des drogues : revue systématique et méta-analyse

Levinsson A, Zolopa C, Vakili F, Udhesister S, Kronfli N, Maheu-Giroux M, Bruneau J, Valerio H, Bajis S, Read P, Martró E, Boucher L, Morris L, Grebely J, Artenie A, Stone J, Vickerman P, Larney S., EClinicalMedicine, 2024

Interventions numériques pour l’usage récréatif du cannabis chez les jeunes adultes : revue systématique, méta-analyse et analyse des techniques de changement de comportement dans des études contrôlées randomisées

Côté J., Chicoine G., Vinette B., Auger P., Rouleau G., Fontaine G., Jutras-Aswad D., Journal of Medical Internet Research, 2024

Bénéfices d’un partenariat pour l’évaluation d’un programme de prévention des surdoses initié par des pairs

Perreault M., Tremblay G., Milton D., Power N., Kucyk C., Perron-Trudel N., Santé Publique, 2024

Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study

Coulaud PJ, Chayama KL, Schwartz C, Purdie A, Lysyshyn M, Ti L, Knight R., Harm Reduct J. 2024

Harm reduction as treatment for Black and Hispanic individuals: response to Scheidell et al

Reed G, Socias ME., Am J Drug Alcohol Abuse. 2024

The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis

Mitra S, Bouck Z, Larney S, Zolopa C, Høj S, Minoyan N, Upham K, Rammohan I, Mok WY, Hayashi K, Milloy MJ, DeBeck K, Scheim A, Werb D., Harm Reduct J. 2024

Évaluation des effets des sites de consommation supervisée sur les prix de l’immobilier à Montréal, Canada, en utilisant des séries temporelles interrompues et des modèles de prix hédoniques

Schaefer M., Panagiotoglou D., Rapports sur la dépendance à la drogue et à l’alcool, 2024

Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk

Fleming T, Boyd J, Gagnon M, Kerr T, McNeil R., Int J Drug Policy. 2024

Évaluation de l’effet des sites de consommation supervisée sur les infections cutanées et des tissus mous chez les personnes qui s’injectent des drogues à Montréal, Canada : une analyse de séries temporelles interrompues

Lim J., Russell W.A., El-Sheikh M., Buckeridge D.L., Panagiotoglou D., Harm Reduction Journal, 2024

L’impact de la thérapie par agonistes opioïdes sur l’usage des opioïdes chez les personnes atteintes de trouble d’usage d’opioïdes sur ordonnance : un essai contrôlé randomisé pragmatique

McAnulty C., Bastien G., Ledjiar O., Socias M.E., Le Foll B., Lim R., Jutras-Aswad D., Addictive Behaviors, 2024

L’effet des sites de consommation supervisée de Montréal sur les infections liées à l’injection chez les personnes qui s’injectent des drogues : une série temporelle interrompue

Lim J., Panagiotoglou D., PLoS ONE, 2024

Évaluation du soutien aux politiques sur l’usage de substances auprès du grand public et des influenceurs politiques dans deux provinces canadiennes

Curtin KD, Thomson M, Hyshka E, Colman I, Wild TC, Belon AP, Nykiforuk CIJ., Sous-traitance des abus Politiques précédentes, 2024

The impact of an unsanctioned compassion club on non-fatal overdose

Kalicum J, Nyx E, Kennedy MC, Kerr T., Int J Drug Policy. 2024

Correction : Évaluation économique de l’effet des programmes à aiguilles et seringues sur la peau, les tissus mous et les infections vasculaires chez les personnes injectant des drogues : une approche de modélisation par microsimulation

Lim J., Russell W.A., El-Sheikh M., Buckeridge D.L., Panagiotoglou D., Harm Reduction Journal, 2024

A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada

Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC., Int J Drug Policy. 2024

Supervised safe consumption sites – lessons and opportunities for North America

Zhu DT, Bajaj SS, Kerr T., Lancet Reg Health Am. 2024

Tendances de la consommation de substances et des méfaits connexes chez les personnes âgées dans les pays à revenu élevé

Sutherland R., Gisev N., Larney S., Addiction, 2024

Opportunities and challenges for implementing drug checking services in British Columbia, Canada: A qualitative study

Chayama KL, Ti L, Arredondo Sanchez Lira J, Coulaud PJ, Bardwell G, Knight R., Int J Drug Policy. 2024

Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada

Speed KA, Choi J, Felicella G, Sedgemore KO, Mok WY, Milloy MJ, DeBeck K, Kerr T, Hayashi K., Int J Drug Policy. 2024

Expanding access to addictions care: Implementation of a 24-hour healthcare provider support line in British Columbia, Canada

Sergeant A, Giesler A, Goel N, Bach P., Addict Sci Clin Pract. 2024

Reasons for Enrolling in Safer Supply Programs: A Longitudinal Qualitative Study on Participant Goals and Related Outcomes in the MySafe Program

Ivsins A, Mansoor M, Bowles J, Bardwell G., J Stud Alcohol Drugs. 2024

Ce que les psychiatres devraient savoir à propos d’un approvisionnement en opioïdes plus sécuritaire sur ordonnance

Bahji A, Danilewitz M, Sachdev A, Mathew N, Lamba W, Rafizadeh R, Chopra N, Dhaliwal A, George TP, Crockford D, Primeau V, Tibbo P, Buckley L, Tanguay R., Can J Psychiatry., 2024

Safer supply and political interference in medical practice: Alberta’s Narcotics Transition Services

Wilson P, Colizza K, Hyshka E., Int J Drug Policy., 2024

Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs

Ivsins A, Bowles JM, Mansoor M, Kerr T, Bardwell G., Int J Drug Policy. 2024

Qualitative findings from North America’s first drug compassion club

Bowles J, Nyx E, Kalicum J, Kerr T., PLoS One. 2024

Impacts of the COVID-19 pandemic on supervised consumption service delivery in Vancouver and Surrey, Canada from the perspective of service providers

Singh Kelsall T, Olding M, Myketiak T, Puri N, Hayashi K, Kerr T, Kennedy MC, Discov Public Health. 2025

Obstacles et facilitateurs à l'accès à la thérapie agoniste des opioïdes pour les adolescents et les jeunes adultes en situation d'itinérance à Vancouver

Gallant K, Nijjar P, DeBeck K, Cui M, Kerr T, J Addict Med

Fréquence de consommation d'opioïdes et ses associations avec des problèmes de vie potentiels pendant le traitement agoniste des opioïdes chez les personnes atteintes de trouble lié à l'utilisation d'opioïdes de type sur ordonnance : résultats exploratoires de l'étude OPTIMA

Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D., Harm Reduct J. 2025

Consommation de cannabis et cessation des opioïdes illicites chez les personnes qui consomment des drogues et vivent avec de la douleur chronique

Kitchen C, Socías ME, Sayre EC, Hayashi K, DeBeck K, Milloy MJ, Kerr T, Reddon H, Drug Alcohol Rev

Comment faire progresser la question des débris d'aiguilles? Une étude qualitative par entretiens avec analyse thématique réflexive, tirée de SANDS (Strategies for Addressing Needle Debris Study)

Jackson, J; Ainsley, E; Perry, S; Gadimova, F; Ens, T; Cameron, T; Francisco, R; Hon, A; Kim, Y; McGill, E; Patel, T; Sodhi, S; Yu, J; Ginn, C., The Canadian Journal of Addiction